stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. MDXG
    stockgist
    HomeTop MoversCompaniesConcepts
    MDXG logo

    MiMedx Group, Inc.

    MDXG
    NASDAQ
    Healthcare
    Biotechnology
    Marietta, GA, US837 employeesmimedx.com
    $3.92
    -0.03(-0.76%)

    Mkt Cap $582M

    $3.81
    $7.96

    52-Week Range

    At A Glance

    1

    MiMedx Group, Inc.

    2

    Revenue is primarily driven by Wound (65.5%) and Surgical (34.5%).

    3

    Most recently: of this report on Form 8-K. Item 7.01 Regulation FD On February 25, 2026 at 4:30 PM Eastern Daylight Time, the Company intends to host a conference call and web (2026-02-25).

    $582M

    Market Cap

    $421M

    Revenue

    $49M

    Net Income

    Employees837
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Wound65.5%($713M)
    Surgical34.5%($376M)
    Activity

    What Changed Recently

    Financial Results
    Feb 24, 2026

    of this report on Form 8-K. Item 7.01 Regulation FD On February 25, 2026 at 4:30 PM Eastern Daylight Time, the Company intends to host a conference call and web

    Regulation FD
    Jan 11, 2026

    Regulation FD Disclosure. MiMedx Group, Inc. (the “Company”) updated its investor presentation on January 12, 2026. A copy of the presentation materials is furn

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    DNTHDianthus Therapeutics, In...$86.51+2.31%$3.3B—
    SNDXSyndax Pharmaceuticals, I...$25.08+5.04%$2.2B-7.3
    NKTRNektar Therapeutics$77.01+1.72%$1.6B-9.2
    INVAInnoviva, Inc.$23.02-1.64%$1.5B6.0
    RAPPRapport Therapeutics, Inc...$33.69+6.36%$1.2B-11.8
    TSHATaysha Gene Therapies, In...$4.38+1.74%$1.1B-13.3
    CVACCVAC$4.66+0.00%$1.0B—
    INBXInhibrx Biosciences, Inc.$63.59-5.17%$929M-7.1
    Analyst View
    Company Profile
    CIK0001376339
    ISINUS6024961012
    CUSIP602496101
    Phone770 651 9100
    Address1775 West Oak Commons Court, NE, Marietta, GA, 30062, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice